5989-2139 Screening compound: 2-{[(1E)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol

5989-2139 Screening compound: 2-{[(1E)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol
5989-2139 Screening compound: 2-{[(1E)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol alternative view

Chemical Structure Depiction of ChemDiv screening compound 5989-2139
2-{[(1E)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5989-2139

Molecular Formula

C14H15BrN2O (C14 H15 BrN2 O)

Compound Name

2-{[(1E)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol

IUPAC name

2-{[(1E)-6-bromo-2349-tetrahydro-1H-carbazol-1-ylidene]amino}ethan-1-ol

SMILES

OCC/N=C(\CCC1)/c2c1c(cc(cc1)Br)c1[nH]2

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

307.19

Hydrogen Bond Acceptors Count

2.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

2.00

Number of Nitrogen and Oxygen Atoms

3

Partition Coefficient, logP

3.030

Distribution Coefficient, logD

0.391

Water Solubility, LogSw

-3.18

Polar Surface Area

35.127

Acid Dissociation Constant (pKa)

15.18

Base Dissociation Constant (pKb)

10.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.70

5989-2139 in Drug Discovery

Included in Screening Libraries

DGK Inhibitors Library (10558 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 5989-2139 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5989-2139?
Check Price and Availability of 5989-2139, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5989-2139 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5989-2139
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5989-2139
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5989-2139 available by request